Printer Friendly

New Market Research Report: Herpes Simplex Virus (HSV) Infections - Pipeline Review, H1 2016.

[ClickPress, Tue Jul 12 2016]

Global Markets Direct's, 'Herpes Simplex Virus (HSV) Infections - Pipeline Review, H1 2016', provides an overview of the Herpes Simplex Virus (HSV) Infections pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Herpes Simplex Virus (HSV) Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Herpes Simplex Virus (HSV) Infections and features dormant and discontinued projects.

Full Report Details at


Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Report Scope

* The report provides a snapshot of the global therapeutic landscape of Herpes Simplex Virus (HSV) Infections

* The report reviews pipeline therapeutics for Herpes Simplex Virus (HSV) Infections by companies and universities/research institutes based on information derived from company and industry-specific sources

* The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

* The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

* The report reviews key players involved Herpes Simplex Virus (HSV) Infections therapeutics and enlists all their major and minor projects

* The report assesses Herpes Simplex Virus (HSV) Infections therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

Copyright [c] 2016 ClickPress Provided by SyndiGate Media Inc. ( ).
COPYRIGHT 2016 SyndiGate Media Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2016 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Date:Jul 12, 2016
Previous Article:Global 4K2K TV Market 2016-2020 - New Study Released.
Next Article:Just Published: "Canada Cardiovascular Procedures Outlook to 2021".

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters